Is Johnson & Johnson (JNJ) One of the Best “Dogs of the Dow” Stocks to Buy for the Rest of 2026?

Johnson & Johnson (NYSE:JNJ) is included among the 10 Best “Dogs of the Dow” Stocks to Buy for the Rest of 2026. On May 13, Leerink Partners upgraded Johnson & Johnson (NYSE:JNJ) to Outperform from Market Perform and raised its price target to $265 from $252.The firm said the company’s “strong new drug momentum” is […]